Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Checked daily

Drug shortages right now

219 drugs (1,504 products) are in shortage or being discontinued in the US, from FDA's shortage list, checked every day. Find yours, see which makers are affected and what's still available.

Checked

Amino Acid Injection Gastroenterology

  • Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05)Otsuka ICU Medical LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03)Otsuka ICU Medical LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Plenamine, Injection, 0.15 (NDC 0264-4500-00)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Plenamine, Injection, 0.15 (NDC 0264-4500-05)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06)Baxter Healthcare · Available · Updated Nov 3, 2026
  • PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18...Baxter Healthcare · Available · Updated Nov 3, 2026
  • Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100...Baxter Healthcare · Unavailable · Reason: Shortage of an inactive ingredient component · Updated Nov 3, 2026Estimated recovery: December 2026
  • Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100...Baxter Healthcare · Available · Updated Nov 3, 2026
  • Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100...Baxter Healthcare · Available · Updated Nov 3, 2026

And 1 more presentations.

Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet Psychiatry

  • Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: November 2026
  • Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Sandoz Inc. · Limited Availability · Reason: Other · Updated Nov 9, 2026Estimated recovery: 1Q 2027
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...SpecGx LLC · Limited Availability · Reason: Demand increase for the drug · Updated Aug 20, 2026Estimated recovery: TBD
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Lannett Company, Inc. · Available · Updated Nov 2, 2026
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Sunrise Pharmaceutical, Inc. · Available · Updated Nov 1, 2026
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Aurobindo Pharma USA · Unavailable · Reason: Shortage of an active ingredient · Updated Nov 4, 2026Estimated availability: April 2027
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Epic Pharma, LLC · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg...Elite Laboratories, Inc. · Available · Updated Nov 3, 2026

And 58 more presentations.

Atropine Sulfate Injection Anesthesia, Neurology, Pediatric

  • Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 17, 2026Discontinuation of the manufacture of the drug
  • Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 17, 2026Discontinuation of the manufacture of the drug
  • Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)Amphastar Pharmaceuticals, Inc. · Available · Updated Nov 6, 2026
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)American Regent, Inc. · Available · Updated Nov 3, 2026On allocation
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 3, 2026Estimated recovery: TBD
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Nov 2, 2026Estimated availability: December 2026
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)Accord Healthcare Inc. · Available · Updated Nov 2, 2026
  • Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026
  • Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)American Regent, Inc. · Available · Updated Nov 3, 2026
  • Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Nov 2, 2026Estimated availability: December 2026
  • Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026

And 2 more presentations.

Azacitidine Injection Oncology

  • Azacitidine, Injection, 100 mg (NDC 16729-306-10)Accord Healthcare Inc. · Available · Updated Nov 2, 2026
  • Azacitidine, Injection, 100 mg (NDC 43598-305-62)Dr. Reddy's Laboratories, Inc. · Available · Updated Nov 12, 2026Available to existing customers
  • Azacitidine, Injection, 100 mg (NDC 68001-313-56)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: TBD
  • Azacitidine, Injection, 100 mg (NDC 72485-201-01)Armas Pharmaceuticals Inc · Limited Availability · Reason: Other · Updated Jun 8, 2026Estimated recovery: TBD
  • Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Product temporarily on backorder. Additional lots will be available the end of October 2026.
  • Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)Fresenius Kabi USA, LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Discontinuation of the manufacture of the drug
  • Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)Eugia US LLC · Unavailable · Reason: Demand increase for the drug · Updated Oct 19, 2026On backorder. Recovery: TBD. Check wholesalers for inventory
  • Vidaza, Injection, 100 mg (NDC 59572-102-01)Bristol Myers Squibb Co. · Available · Updated Nov 2, 2026

Bacitracin Ophthalmic Ointment Anti-Infective, Ophthalmology

  • Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)Padagis US LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 23, 2026Shortage is estimated for 15 additional months

Bupivacaine Hydrochloride Injection Anesthesia

  • Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL 5mg / 1mL (NDC 72266-263-10)Onesource Specialty Pte Ltd · Available · Updated Sep 18, 2026Distributed by Fosun Pharma USA Inc.
  • Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)Aspiro Pharma Limited · Available · Updated Jul 17, 2026
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)Aspiro Pharma Limited · Available · Updated Jul 17, 2026
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)Eugia US LLC · Available · Updated Oct 19, 2026Check wholesalers for inventory
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)Eugia US LLC · Available · Updated Oct 19, 2026Check wholesalers for inventory
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)Eugia US LLC · Available · Updated Oct 19, 2026Check wholesalers for inventory
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)Somerset Therapeutics, LLC · Unavailable · Reason: Other · Updated Oct 27, 2026Estimated recovery: June 2027
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)Somerset Therapeutics, LLC · Unavailable · Reason: Other · Updated Oct 27, 2026Estimated recovery: June 2027
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)Kindos Pharmaceuticals Co. Ltd. · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated May 5, 2026Meitheal Pharmaceuticals is distributor/labeler
  • Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)Kindos Pharmaceuticals Co. Ltd. · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated May 5, 2026Meitheal Pharmaceuticals is distributor/labeler
  • Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026

And 42 more presentations.

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection Anesthesia

  • Bupivacaine Hydrochloride with Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Bupivacaine Hydrochloride with Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Bupivacaine Hydrochloride with Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Bupivacaine Hydrochloride with Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Bupivacaine Hydrochloride with Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Bupivacaine Hydrochloride with Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 125 mg/50 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 25 mg/10 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 75 mg/30 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial...Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026

And 11 more presentations.

Carboplatin Injection Oncology

  • Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: December 2028
  • Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: January 2027
  • Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: March 2027
  • Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: December 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)Teyro Labs · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug
  • Carboplatin, Injection, 150 mg/15 mL (NDC 69339-365-15)Teyro Labs · Available · Updated Oct 20, 2026Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)
  • Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)Gland Pharma Limited · Available · Updated Oct 21, 2026Distributed by BPI Labs, LLC
  • Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

And 20 more presentations.

Cefotaxime Sodium Powder, for Solution Anti-Infective, Pediatric

  • Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)SteriMax, Inc. · Available · Updated Jun 15, 2026
  • Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)SteriMax, Inc. · Available · Updated Jun 15, 2026
  • Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD

Clindamycin Phosphate Injection Anti-Infective

  • Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)Pfizer Inc. · Being discontinued Jun 1, 2026 · Updated Jun 1, 2026Discontinuation of the manufacture of the drug
  • Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)Sandoz Inc. · Available · Updated Nov 9, 2026Civica Label
  • Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)Sagent Pharmaceuticals · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Selling through remaining short-dated inventory (Dec 2026).

And 8 more presentations.

Conivaptan Hydrochloride Injection Cardiovascular

  • Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)Cumberland Pharmaceuticals Inc. · Unavailable · Reason: Delay in shipping of the drug · Updated Oct 15, 2026Estimated recovery: TBD

Cromolyn Sodium Concentrate Pulmonary/Allergy

  • Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 16571-600-96)Rising Pharma Holdings, Inc. · Available · Updated Sep 1, 2026
  • Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52)Micro Labs LTD · Available · Updated Nov 2, 2026
  • Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96)Ailex Pharmaceuticals · Limited Availability · Reason: Other · Updated Nov 2, 2026No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2
  • Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)Ailex Pharmaceuticals · Limited Availability · Reason: Other · Updated Nov 2, 2026No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300
  • Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96)Ailex Pharmaceuticals · Available · Updated Nov 2, 2026Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195
  • Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96)Mylan Specialty, a Viatris Company · Available · Updated Nov 3, 2026

Desmopressin Acetate Spray Hematology

  • Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0)Ferring · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated May 1, 2026Estimated recovery: TBD
  • Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)Apotex Corp. · Limited Availability · Reason: Delay in shipping of the drug · Updated Oct 15, 2026Replenishment expected mid to late November 2026
  • Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)Ferring · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated May 1, 2026Estimated recovery: TBD
  • Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00)Ferring · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated May 1, 2026Estimated recovery: TBD

Dexamethasone Sodium Phosphate Injection Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology

  • Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Product will be made available as it is released.
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)Eugia US LLC · Available · Updated Oct 19, 2026Check wholesalers for inventory
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release January 2027. Check wholesalers for inventory.
  • Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release January 2027. Check wholesalers for inventory.
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Product temporarily on backorder. Additional lots will be available in the November 2026 timeframe.
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional product will be made available as it is released.
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)Fresenius Kabi USA, LLC · Available · Reason: Demand increase for the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026

And 4 more presentations.

Dexmedetomidine Hydrochloride Injection Anesthesia

  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional product will be made available as it is released.
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Sep 15, 2026Discontinuation of the manufacture of the drug
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)Accord Healthcare Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Sep 15, 2026Discontinuation of the manufacture of the drug
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)Par Health, USA LLC · Unavailable · Reason: Other · Updated Nov 2, 2026Please check wholesalers for inventory
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)HQ Specialty Pharma · Available · Updated Nov 2, 2026Marketed by WG Critical Care
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)HQ Specialty Pharma · Available · Updated Nov 2, 2026Marketed by WG Critical Care
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)Eugia US LLC · Available · Updated Oct 19, 2026Check wholesalers for inventory
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 14, 2026Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229
  • Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)Azurity Pharmaceuticals, Inc · Available · Updated Oct 15, 2026Distributed by Wilshire Pharmaceuticals, Inc.
  • Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)Azurity Pharmaceuticals, Inc · Available · Updated Oct 15, 2026Distributed by Civica

And 43 more presentations.

Dextrose Monohydrate 10% Injection Endocrinology/Metabolism, Gastroenterology, Other, Pediatric

  • Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19)Otsuka ICU Medical LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00)B. Braun Medical Inc. · Available · Updated Oct 19, 2026
  • Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10)B. Braun Medical Inc. · Available · Updated Oct 19, 2026
  • Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20)B. Braun Medical Inc. · Available · Updated Oct 19, 2026

Dextrose Monohydrate 5% Injection Endocrinology/Metabolism, Gastroenterology, Other, Pediatric

  • Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61)Otsuka ICU Medical LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.

And 21 more presentations.

Dextrose Monohydrate 50% Injection Endocrinology/Metabolism, Gastroenterology, Pediatric

  • Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)Amphastar Pharmaceuticals, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 6, 2026

Dextrose Monohydrate 70% Injection Endocrinology/Metabolism, Gastroenterology, Other, Pediatric

  • DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19)Otsuka ICU Medical LLC · Available · Updated Nov 3, 2026This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)Baxter Healthcare · Available · Updated Nov 3, 2026

Dobutamine Hydrochloride Injection Cardiovascular, Pediatric, Renal

  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)Hainan Poly Pharm. Co., Ltd. · Available · Updated Oct 21, 2026Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988
  • Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay

Dopamine Hydrochloride Injection Cardiovascular

  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)Baxter Healthcare · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: November 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
  • Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe.
  • Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
  • Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

Echothiophate Iodide Ophthalmic Solution Ophthalmology

  • Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)Fera Pharmaceuticals · Available · Updated Nov 2, 2026Available through limited distribution by Walgreens Specialty Pharmacy.

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection Anesthesia, Pediatric

  • Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: August 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory

And 7 more presentations.

Etomidate Injection Anesthesia

  • Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Novaplus label
  • Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Novaplus label
  • Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional product will be made available as it is released.
  • Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional product will be made available as it is released.
  • Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)Gland Pharma Limited · Available · Updated Oct 21, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
  • Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)Gland Pharma Limited · Available · Updated Oct 21, 2026Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.
  • Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Distributed by Civica
  • Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Distributed by Civica
  • Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)Caplin Steriles, Ltd. · Available · Updated Jun 16, 2026Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586
  • Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)Caplin Steriles, Ltd. · Available · Updated Jun 16, 2026Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586
  • Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)Eugia US LLC · Unavailable · Reason: Demand increase for the drug · Updated Oct 19, 2026On backorder. Recovery: TBD. Check wholesalers for inventory

And 3 more presentations.

Fentanyl Citrate Injection Analgesia/Addiction, Pediatric

  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
  • Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
  • Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
  • Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
  • Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
  • Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.
  • Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be scheduled for manufacturing to meet demand. Product will be made available as it is released.

And 5 more presentations.

Flurazepam Hydrochloride Capsule Neurology, Other

  • Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)Rising Pharma Holdings, Inc. · Unavailable · Reason: Regulatory delay · Updated Sep 1, 2026Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
  • Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)Chartwell Molecular Holdings LLC · Available · Updated Sep 15, 2026
  • Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)Chartwell Molecular Holdings LLC · Available · Updated Sep 15, 2026
  • Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)Rising Pharma Holdings, Inc. · Unavailable · Reason: Regulatory delay · Updated Sep 1, 2026Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
  • Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)Chartwell Molecular Holdings LLC · Available · Updated Sep 15, 2026
  • Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)Chartwell Molecular Holdings LLC · Available · Updated Sep 15, 2026

Furosemide Injection Cardiovascular

  • Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)Accord Healthcare Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Nov 2, 2026Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA
  • Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)Avet Pharmaceuticals, Inc. · Available · Updated Nov 2, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)Avet Pharmaceuticals, Inc. · Available · Updated Nov 2, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)Avet Pharmaceuticals, Inc. · Available · Updated Nov 2, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)Gland Pharma Limited · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 21, 2026Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product
  • Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)Gland Pharma Limited · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 21, 2026Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product
  • Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)Gland Pharma Limited · Being discontinued Apr 28, 2026 · Updated Apr 28, 2026Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
  • Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 20267 mos expiry (6/30/2027) available on request. Check wholesaler for inventory.

And 12 more presentations.

Furosemide Oral Solution Cardiovascular

  • Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 27, 2026
  • Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 27, 2026
  • Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 27, 2026

Heparin Sodium Injection Hematology

  • Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)B. Braun Medical Inc. · Limited Availability · Reason: Other · Updated Nov 10, 2026Estimated recovery: late Q1 2027; Manufacturing delays
  • Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)B. Braun Medical Inc. · Limited Availability · Reason: Other · Updated Nov 10, 2026Estimated recovery: late Q1 2027; Manufacturing delays
  • Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)Baxter Healthcare · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: January 2027
  • Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.

Hydromorphone Hydrochloride Injection Analgesia/Addiction

  • Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release not available at this time. Check wholesalers for inventory.
  • Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery and Estimated Recovery: December 2026
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: November 2026
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesaler for inventory

And 11 more presentations.

Hydroxocobalamin Injection Other

  • Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)BTG International Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches...
  • Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: mid-November 2026

Ifosfamide Injection Oncology, Pediatric

  • IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)Baxter Healthcare · Available · Updated Nov 3, 2026
  • IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)SteriMax, Inc. · Available · Updated Sep 8, 2026To place an order, please contact GlobalRX at [email protected] or (919) 245-8418
  • Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10)Fresenius Kabi USA, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
  • Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.

Isocarboxazid Tablet Psychiatry

  • Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01)Lifsa Drugs LLC · Limited Availability · Reason: Other · Updated Aug 6, 2026Estimated recovery: TBD

Ketorolac Tromethamine Injection Analgesia/Addiction

  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)Baxter Healthcare · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: December 2026
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2027
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Gland Pharma Limited · Available · Updated Oct 21, 2026
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)Sagent Pharmaceuticals · Limited Availability · Reason: Delay in shipping of the drug · Updated Nov 6, 2026Estimated recovery: Mid-November 2026, Product in transit and expected to arrive week of Nov 12th
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)Alembic Pharmaceuticals · Available · Updated May 15, 2026
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Gland Pharma Limited · Available · Updated Oct 21, 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)Sagent Pharmaceuticals · Available · Updated Nov 6, 2026
  • Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)Sagent Pharmaceuticals · Unavailable · Reason: Demand increase for the drug · Updated Nov 6, 2026Product in transit with expected delivery in December 2026

And 10 more presentations.

Lidocaine Hydrochloride Injection Anesthesia, Pediatric

  • Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)Anthea Pharma · Available · Updated Nov 2, 2026Distributed by Avenacy, LLC
  • Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay
  • Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.

And 50 more presentations.

Liraglutide Injection Endocrinology/Metabolism

  • Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026
  • Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026
  • Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)Novo Nordisk, Inc. · Available · Updated Sep 22, 2026Distributed by Teva
  • Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)Novo Nordisk, Inc. · Available · Updated Sep 22, 2026Distributed by Teva
  • Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)Teva Pharmaceuticals USA, Inc. · Being discontinued May 14, 2026 · Updated May 14, 2026Discontinuation of the manufacture of the drug
  • Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)Novo Nordisk, Inc. · Being discontinued Aug 25, 2026 · Updated Aug 25, 2026Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug
  • Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)Novo Nordisk, Inc. · Limited Availability · Reason: Delay in shipping of the drug · Updated Sep 22, 2026Estimated shortage duration: TBD
  • Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)Novo Nordisk, Inc. · Limited Availability · Reason: Delay in shipping of the drug · Updated Sep 22, 2026Estimated shortage duration: TBD

Lisdexamfetamine Dimesylate Capsule Psychiatry

  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated May 12, 2026Available on allocation
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)SpecGx LLC · Available · Updated Aug 20, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)Lannett Company, Inc. · Available · Updated Nov 2, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)Rhodes Pharmaceuticals L.P. · Available · Updated Jun 24, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)Solco Healthcare US, LLC · Limited Availability · Reason: Shortage of an active ingredient · Updated Jun 29, 2026On allocation
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)Alvogen · Available · Updated Nov 2, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)Sun Pharmaceutical Industries, Inc. · Limited Availability · Reason: Other · Updated Oct 30, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)Apotex Corp. · Available · Updated Oct 15, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)Elite Laboratories, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 3, 2026Estimated recovery: TBD
  • Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Shortage of an active ingredient · Updated Oct 14, 2026Available on allocation
  • Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)Mylan Pharmaceuticals Inc., a Viatris Company · Available · Updated Nov 3, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)SpecGx LLC · Available · Updated Aug 20, 2026
  • Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026

And 75 more presentations.

Lisdexamfetamine Dimesylate Tablet, Chewable Psychiatry

  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)Sun Pharmaceutical Industries, Inc. · Available · Updated Oct 30, 2026
  • Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)Novadoz Pharmaceuticals LLC · Available · Updated Sep 16, 2026
  • Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)Takeda Pharmaceuticals USA Inc. · Available · Updated Nov 2, 2026
  • Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)Takeda Pharmaceuticals USA Inc. · Available · Updated Nov 2, 2026
  • Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)Takeda Pharmaceuticals USA Inc. · Available · Updated Nov 2, 2026

And 3 more presentations.

Lorazepam Injection Neurology

  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)Amphastar Pharmaceuticals, Inc. · Available · Updated Nov 6, 2026
  • Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery and Estimated Recovery: June 2027
  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD

Meperidine Hydrochloride Injection Analgesia/Addiction

  • Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.

Methotrexate Sodium Injection Rheumatology, Oncology

  • Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesaler for inventory
  • Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: TBD
  • Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated Recovery: Novemeber 2026
  • Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: TBD
  • Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)Accord Healthcare Inc. · Available · Updated Nov 2, 2026
  • Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)Accord Healthcare Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Short dated inventory with expiry of 8/31/2027 available; Estimated recovery: Jan 2027
  • Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesaler for inventory
  • Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available.
  • Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released.

Methylphenidate Film, Extended Release Psychiatry

  • Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)Noven Pharmaceuticals, Inc. · Available · Updated Oct 16, 2026Distributed by Padagis US LLC
  • Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)Noven Pharmaceuticals, Inc. · Available · Updated Oct 16, 2026Distributed by Padagis US LLC
  • Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)Noven Pharmaceuticals, Inc. · Available · Updated Oct 16, 2026Distributed by Padagis US LLC
  • Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)Noven Pharmaceuticals, Inc. · Available · Updated Oct 16, 2026Distributed by Padagis US LLC

Methylphenidate Hydrochloride Tablet, Extended Release Psychiatry

  • Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)Janssen Pharmaceuticals · Available · Updated Nov 3, 2026
  • Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)Janssen Pharmaceuticals · Available · Updated Nov 3, 2026
  • Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)Janssen Pharmaceuticals · Available · Updated Nov 3, 2026
  • Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)Janssen Pharmaceuticals · Available · Updated Nov 3, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 30, 2026Currently not marketed
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)Lannett Company, Inc. · Available · Updated Nov 2, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 30, 2026Currently not marketed
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)Teva Pharmaceuticals USA, Inc. · Available · Updated Nov 2, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)Lannett Company, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: November 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 30, 2026Currently not marketed
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)Teva Pharmaceuticals USA, Inc. · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: November 2026

And 19 more presentations.

Methylprednisolone Acetate Injection Rheumatology

  • Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)Pfizer Inc. · Available · Updated Nov 6, 2026
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)Pfizer Inc. · Unavailable · Reason: Demand increase for the drug · Updated Nov 6, 2026Next Delivery: November 2026; Estimated Recovery: December 2026
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)Pfizer Inc. · Limited Availability · Reason: Other · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)Pfizer Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)Pfizer Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 6, 2026Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)Pfizer Inc. · Limited Availability · Reason: Other · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)Pfizer Inc. · Unavailable · Reason: Demand increase for the drug · Updated Nov 6, 2026Next Delivery: November 2026; Estimated Recovery: December 2026
  • Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)Pfizer Inc. · Available · Updated Nov 6, 2026
  • Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)Pfizer Inc. · Available · Updated Nov 6, 2026
  • Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)Pfizer Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 6, 2026Limited Supply Available. Next Delivery and Estimated Recovery: December 2026
  • Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)Pfizer Inc. · Limited Availability · Reason: Other · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)Sagent Pharmaceuticals · Available · Updated Nov 6, 2026
  • Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)Sagent Pharmaceuticals · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 6, 2026Next supply due in March 2027

And 8 more presentations.

Metronidazole Injection Anti-Infective

  • Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24)InfoRLife SA · Limited Availability · Reason: Other · Updated Nov 2, 2026Labeler: Hospira Inc.
  • Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)Gland Pharma Limited · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Oct 21, 2026Discontinuation of the manufacture of the drug
  • Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82)InfoRLife SA · Limited Availability · Reason: Other · Updated Nov 2, 2026Estimated recovery: November 2026; Marketed by Sagent Pharmaceuticals

Midazolam Hydrochloride Injection Anesthesia, Neurology

  • Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Demand increase for the drug · Updated Nov 9, 2026Next Delivery: December 2026; Estimated Recovery: March 2027
  • Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: June 2027
  • Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Next Estimated Delivery and Estimated Recovery: December 2026
  • Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2305-50)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery: December 2027; Estimated Recovery: March 2028; Shortage per Manufacturer: Manufacturing Delay
  • Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027
  • Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Demand increase for the drug · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2026
  • Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-49)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)Avet Pharmaceuticals, Inc. · Available · Updated Nov 2, 2026
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)Gland Pharma Limited · Unavailable · Reason: Other · Updated Oct 21, 2026Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory

And 15 more presentations.

Morphine Sulfate Injection Analgesia/Addiction

  • Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
  • Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)Piramal Critical Care Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 10, 2026On allocation
  • Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)Piramal Critical Care Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 10, 2026On allocation
  • Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)Amphastar Pharmaceuticals, Inc. · Available · Updated Nov 6, 2026
  • Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 9, 2026Discontinuation of the manufacture of the drug
  • Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay
  • Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay
  • Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026

And 9 more presentations.

Penicillin G Benzathine Injection Anti-Infective

  • Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10)Pfizer Inc. · Limited Availability · Reason: Other · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10)Pfizer Inc. · Limited Availability · Reason: Other · Updated Nov 6, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)Pfizer Inc. · Unavailable · Reason: Other · Updated Nov 6, 2026Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay
  • Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)Laboratorios Atral · Available · Updated Nov 6, 2026

Pentostatin Injection Oncology

  • Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: December 2028

Promethazine Hydrochloride Injection Analgesia/Addiction, Gastroenterology, Pediatric, Pulmonary/Allergy

  • Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Estimated recovery: TBD
  • Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
  • Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)XGen Pharmaceuticals DJB, Inc. · Available · Updated Sep 22, 2026
  • Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots are scheduled to be manufactured. Product will be made available as it is released.
  • Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)XGen Pharmaceuticals DJB, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Sep 22, 2026Estimated recovery: TBD

Propranolol Hydrochloride Injection Cardiovascular

  • Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Shortage of an active ingredient · Updated Oct 14, 2026Estimated recovery: TBD
  • Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release: November 2026. Check wholesalers for inventory.

Quinapril Hydrochloride Tablet Cardiovascular

  • Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09)Solco Healthcare US, LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Jun 29, 2026Not available. Long-term backorder for all NDCs. No estimated release date at this time.
  • Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)Lupin Pharmaceuticals, Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 13, 2026Estimated recovery: TBD
  • Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)Solco Healthcare US, LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Jun 29, 2026Not available. Long-term backorder for all NDCs. No estimated release date at this time.
  • Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)Lupin Pharmaceuticals, Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 13, 2026Estimated recovery: TBD
  • Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09)Solco Healthcare US, LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Jun 29, 2026Not available. Long-term backorder for all NDCs. No estimated release date at this time.
  • Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)Lupin Pharmaceuticals, Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 13, 2026Estimated recovery: TBD
  • Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09)Solco Healthcare US, LLC · Unavailable · Reason: Shortage of an active ingredient · Updated Jun 29, 2026Not available. Long-term backorder for all NDCs. No estimated release date at this time.
  • Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)Lupin Pharmaceuticals, Inc. · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 13, 2026Estimated recovery: TBD

Quinapril/Hydrochlorothiazide Tablet Cardiovascular

  • Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)Aurobindo Pharma USA · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 4, 2026Discontinuation of the manufacture of the drug
  • Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026
  • Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)Chartwell Molecular Holdings LLC · Available · Updated Nov 3, 2026

Remifentanil Hydrochloride Injection Analgesia/Addiction

  • Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)Fresenius Kabi USA, LLC · Available · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Check wholesalers for inventory
  • Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Estimated recovery: TBD
  • Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Ultiva, Injection, 2 mg (NDC 72078-035-02)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Ultiva, Injection, 5 mg (NDC 72078-036-05)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026

Rifampin Capsule Anti-Infective

  • Rifampin, Capsule, 150 mg (NDC 42806-801-01)Epic Pharma, LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Discontinuation of the manufacture of the drug
  • Rifampin, Capsule, 150 mg (NDC 42806-801-30)Epic Pharma, LLC · Available · Updated Nov 3, 2026
  • Rifampin, Capsule, 150 mg (NDC 68180-658-06)Lupin Pharmaceuticals, Inc. · Available · Updated Oct 13, 2026
  • Rifampin, Capsule, 300 mg (NDC 42806-799-01)Epic Pharma, LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Discontinuation of the manufacture of the drug
  • Rifampin, Capsule, 300 mg (NDC 42806-799-05)Epic Pharma, LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Discontinuation of the manufacture of the drug
  • Rifampin, Capsule, 300 mg (NDC 42806-799-30)Epic Pharma, LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Discontinuation of the manufacture of the drug
  • Rifampin, Capsule, 300 mg (NDC 42806-799-60)Epic Pharma, LLC · Available · Updated Nov 3, 2026
  • Rifampin, Capsule, 300 mg (NDC 68180-659-06)Lupin Pharmaceuticals, Inc. · Available · Updated Oct 13, 2026
  • Rifampin, Capsule, 300 mg (NDC 68180-659-07)Lupin Pharmaceuticals, Inc. · Available · Updated Oct 13, 2026

Rifampin Injection Anti-Infective

  • Rifadin, Injection, 600 mg (NDC 0068-0597-01)Sanofi-Aventis U.S. LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 6, 2026Discontinuation of the manufacture of the drug
  • Rifadin, Injection, 600 mg (NDC 0068-0660-50)Sanofi-Aventis U.S. LLC · Available · Updated Nov 6, 2026
  • Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)Sanofi-Aventis U.S. LLC · Being discontinued Apr 20, 2026 · Updated Apr 20, 2026Discontinuation of the manufacture of the drug
  • Rifampin, Injection, 600 mg (NDC 63323-351-20)Fresenius Kabi USA, LLC · Limited Availability · Reason: Other · Updated Nov 3, 2026Check wholesalers for inventory
  • Rifampin, Injection, 600 mg (NDC 67457-445-60)Mylan Institutional, a Viatris Company · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: Q4 2026

Riluzole Oral Suspension Neurology

  • Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) · Available · Updated Oct 15, 2026
  • Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) · Available · Updated Oct 15, 2026
  • Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) · Available · Updated Oct 15, 2026
  • Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.) · Unavailable · Reason: Requirements related to complying with good manufacturing practices · Updated Oct 15, 2026Estimated recovery: TBD

Rocuronium Bromide Injection Anesthesia

  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be available. Product will be made available as it is released.
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be available. Product will be made available as it is released.
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)Sandoz Inc. · Available · Updated Nov 9, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)Sagent Pharmaceuticals · Available · Updated Nov 6, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)Mylan Institutional, a Viatris Company · Available · Updated Nov 3, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)Meitheal Pharmaceuticals, Inc. · Available · Updated Aug 27, 2026
  • Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026

And 11 more presentations.

Ropivacaine Hydrochloride Injection Anesthesia

  • Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026
  • Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Delay in shipping of the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release not available at this time. Check wholesalers for inventory.
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Estimated recovery: TBD
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026
  • Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026
  • Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026
  • Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026

And 34 more presentations.

Sodium Acetate Injection Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition

  • Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be available. Product will be made available as it is released.
  • Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)Milla Pharmaceuticals · Available · Updated Oct 15, 2026
  • Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)Somerset Therapeutics, LLC · Available · Updated Oct 27, 2026
  • Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)Milla Pharmaceuticals · Available · Updated Oct 15, 2026
  • Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be available. Product will be made available as it is released.
  • Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)Milla Pharmaceuticals · Available · Updated Oct 15, 2026
  • Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)Milla Pharmaceuticals · Limited Availability · Reason: Other · Updated Oct 15, 2026Estimated recovery: TBD

Sodium Bicarbonate Injection Endocrinology/Metabolism, Gastroenterology, Pediatric

  • Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay
  • Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027
  • Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)Exela Pharma Sciences, LLC · Available · Updated Oct 15, 2026
  • Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory.
  • Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)Hospira, Inc., a Pfizer Company · Unavailable · Reason: Other · Updated Nov 9, 2026Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)Exela Pharma Sciences, LLC · Available · Updated Oct 15, 2026
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)Exela Pharma Sciences, LLC · Available · Updated Oct 15, 2026
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)Amphastar Pharmaceuticals, Inc. · Limited Availability · Reason: Demand increase for the drug · Updated Nov 6, 2026Available on allocation
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)Long Grove Pharmaceuticals LLC · Available · Updated Oct 16, 2026

Sterile Water Injection Other

  • Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01)Nephron Pharmaceuticals Corporation · Limited Availability · Reason: Other · Updated Aug 4, 2026Small amount of inventory available with 12/31/2026 dating
  • Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug · Updated Oct 14, 2026Additional lots will be available in the November 2026 timeframe. Product will be made available as it is released.
  • Sterile Water, Injection, 10 mL Single Dose Plastic Fliptop Vial Novaplus (NDC 0409-0024-10)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30)Medefil, Inc. · Available · Updated Nov 2, 2026
  • Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory

Sterile Water Irrigant Gastroenterology, Other, Pediatric

  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10)B. Braun Medical Inc. · Available · Updated Nov 10, 2026
  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03)Otsuka ICU Medical LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22)Otsuka ICU Medical LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09)Otsuka ICU Medical LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36)Otsuka ICU Medical LLC · Unavailable · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
  • Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03)Baxter Healthcare · Available · Updated Nov 3, 2026
  • Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04)Baxter Healthcare · Limited Availability · Reason: Other · Updated Nov 3, 2026Estimated Recovery: February 2027

Streptozocin Powder, For Solution Oncology

  • Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)Esteve Pharmaceuticals, S.A. · Available · Updated Sep 16, 2026
  • Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)Teva Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Nov 2, 2026Estimated recovery: TBD

Sufentanil Citrate Injection Analgesia/Addiction, Pediatric

  • Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Not currently manufactured
  • Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Not currently manufactured
  • Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other · Updated Oct 14, 2026Not currently manufactured
  • Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Other · Updated Nov 9, 2026Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

Technetium TC-99M Pyrophosphate Kit Injection Medical Imaging

  • CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Other · Updated Oct 30, 2026Estimated recovery: TBD
  • CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Other · Updated Oct 30, 2026Estimated recovery: TBD
  • Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)Curium US LLC · Limited Availability · Reason: Shortage of an active ingredient · Updated Nov 2, 2026On allocation

Triamcinolone Hexacetonide Injection Rheumatology

  • Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)Medexus · Available · Updated Sep 15, 2026

Valproate Sodium Injection Neurology

  • Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)Fresenius Kabi USA, LLC · Unavailable · Reason: Demand increase for the drug · Updated Nov 3, 2026Next release November 2026. Check wholesalers for inventory.
  • Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)Hikma Pharmaceuticals USA, Inc. · Available · Updated Oct 14, 2026Additional lots will be available. Product will be made available as it is released.

Activated Charcoal Oral Suspension Other

  • Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)Padagis US LLC · Being discontinued May 15, 2026 · Updated May 15, 2026Discontinuation of the manufacture of the drug
  • Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74)Padagis US LLC · Being discontinued May 15, 2026 · Updated May 15, 2026Discontinuation of the manufacture of the drug
  • Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76)Padagis US LLC · Being discontinued May 15, 2026 · Updated May 15, 2026Discontinuation of the manufacture of the drug
  • Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)Padagis US LLC · Being discontinued May 15, 2026 · Updated May 15, 2026Discontinuation of the manufacture of the drug
  • Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76)Padagis US LLC · Being discontinued May 15, 2026 · Updated May 15, 2026Discontinuation of the manufacture of the drug

Adalimumab-adaz Injection Rheumatology

  • Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)Sandoz Inc. · Being discontinued Jan 13, 2026 · Updated Jan 13, 2026Equivalent Sandoz format is available.
  • Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)Sandoz Inc. · Being discontinued Jan 13, 2026 · Updated Jan 13, 2026Equivalent Sandoz format is available.
  • Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)Sandoz Inc. · Being discontinued Jan 13, 2026 · Updated Jan 13, 2026Equivalent Sandoz format is available.
  • Hyrimoz, Injection, Kit (NDC 61314-517-36)Sandoz Inc. · Being discontinued Jan 13, 2026 · Updated Jan 13, 2026Equivalent Sandoz format is available.
  • Hyrimoz, Injection, Kit (NDC 61314-531-64)Sandoz Inc. · Being discontinued Jan 13, 2026 · Updated Jan 13, 2026Equivalent Sandoz format is available.

Allopurinol Tablet Oncology, Renal, Rheumatology

  • Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Feb 19, 2026 · Updated Feb 19, 2026Discontinuation of the manufacture of the drug
  • Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)Teva Pharmaceuticals USA, Inc. · Being discontinued Feb 19, 2026 · Updated Feb 19, 2026Discontinuation of the manufacture of the drug
  • Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Feb 19, 2026 · Updated Feb 19, 2026Discontinuation of the manufacture of the drug
  • Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)Teva Pharmaceuticals USA, Inc. · Being discontinued Feb 19, 2026 · Updated Feb 19, 2026Discontinuation of the manufacture of the drug

Alteplase Injection Cardiovascular, Hematology, Neurology

  • Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27)Genentech, Inc · Being discontinued May 21, 2026 · Updated May 21, 2026Discontinuation of the 100mg vial configuration

Ampicillin Sodium Injection Anti-Infective

  • Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95)Sandoz Inc. · Being discontinued Dec 8, 2025 · Updated Dec 8, 2025Discontinuation of private label only
  • Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92)Sandoz Inc. · Being discontinued Dec 8, 2025 · Updated Dec 8, 2025Discontinuation of private label only
  • Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95)Sandoz Inc. · Being discontinued Dec 8, 2025 · Updated Dec 8, 2025Discontinuation of private label only
  • Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95)Sandoz Inc. · Being discontinued Dec 8, 2025 · Updated Dec 8, 2025Discontinuation of private label only
  • Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92)Sandoz Inc. · Being discontinued Dec 8, 2025 · Updated Dec 8, 2025Discontinuation of private label only

Anagrelide Hydrochloride Capsule Hematology

  • Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.
  • Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.

Aprepitant Oral Powder for Suspension Gastroenterology

  • Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)Merck Sharp & Dohme LLC · Being discontinued Apr 8, 2026 · Updated Apr 8, 2026To be discontinued in approximately early-September 2026.

Arsenic Trioxide Injection Oncology

  • Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)Ingenus Pharmaceuticals LLC · Being discontinued Feb 24, 2026 · Updated Feb 24, 2026A business decision was made to discontinue manufacture of the drug.
  • Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)Fresenius Kabi USA, LLC · Being discontinued Sep 21, 2026 · Updated Sep 21, 2026Discontinuation of the manufacture of the drug

Aspirin Suppository Analgesia/Addiction, Cardiovascular

  • Aspirin, Suppository, 300 mg (NDC 0574-7034-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Azithromycin Injection Anti-Infective

  • Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)Pfizer Inc. · Being discontinued Jan 20, 2026 · Updated Jan 20, 2026Discontinuation of the manufacture of the drug.

Azithromycin Tablet Anti-Infective

  • Zithromax, Tablet, 250 mg (NDC 0069-4061-01)Pfizer Inc. · Being discontinued Apr 9, 2026 · Updated Apr 9, 2026Discontinuation of the manufacture of the drug
  • Zithromax, Tablet, 500 mg (NDC 0069-3070-30)Pfizer Inc. · Being discontinued Apr 9, 2026 · Updated Apr 9, 2026Discontinuation of the manufacture of the drug

Belladonna and Opium Suppository Analgesia/Addiction

  • Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Bendamustine Hydrochloride Injection, Solution Oncology

  • Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.) · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026A business decision has been made to discontinue manufacture of the drug.

Benztropine Mesylate Injection Neurology

  • Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)Fresenius Kabi USA, LLC · Being discontinued Jan 27, 2026 · Updated Jan 27, 2026Discontinuation of the manufacture of the drug

Calcitriol Capsule Endocrinology/Metabolism

  • Calcitriol, Capsule, .25 ug (NDC 0093-7352-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Dec 4, 2025 · Updated Dec 4, 2025A business decision was made to discontinue manufacture of the drug
  • Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Dec 4, 2025 · Updated Dec 4, 2025A business decision was made to discontinue manufacture of the drug

Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution Renal

  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.
  • DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100...Vantive US Healthcare LLC · Being discontinued Aug 3, 2026 · Updated Aug 3, 2026A business decision was made to discontinue manufacture of the drug.

And 3 more presentations.

Carbamazepine Capsule, Extended Release Neurology

  • Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)Takeda Pharmaceuticals USA Inc. · Being discontinued Dec 19, 2025 · Updated Dec 19, 2025Discontinuation of the manufacture of the drug
  • Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)Takeda Pharmaceuticals USA Inc. · Being discontinued Dec 19, 2025 · Updated Dec 19, 2025Discontinuation of the manufacture of the drug
  • Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)Takeda Pharmaceuticals USA Inc. · Being discontinued Dec 19, 2025 · Updated Dec 19, 2025Discontinuation of the manufacture of the drug

Caspofungin Acetate Injection Anti-Infective

  • Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug
  • Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug
  • Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10)Fresenius Kabi USA, LLC · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026Discontinuation of the manufacture of the drug

Cefazolin in Dextrose Injection Anti-Infective

  • Cefazolin in Dextrose, Injection, 1g/50 mL (NDC 0338-3503-41)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug
  • Cefazolin in Dextrose, Injection, 2g/100mL (NDC 0338-3508-41)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug
  • Cefazolin in Dextrose, Injection, 3g/150mL (NDC 0338-0096-06)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug

Cefepime Hydrochloride Injection Anti-Infective

  • Cefepime Hydrochloride in Plastic Container, Injection, 1g/50 mL (NDC 0338-1301-41)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug
  • Cefepime Hydrochloride in Plastic Container, Injection, 2g/100mL (NDC 0338-1301-48)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug
  • Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)Fresenius Kabi USA, LLC · Being discontinued Feb 10, 2026 · Updated Feb 10, 2026Discontinuation of the manufacture of the drug.
  • Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)Fresenius Kabi USA, LLC · Being discontinued Feb 10, 2026 · Updated Feb 10, 2026Discontinuation of the manufacture of the drug.

Ceftazidime Injection Anti-Infective

  • Tazicef, Injection, 1 g (NDC 0409-5092-16)Hospira, Inc., a Pfizer Company · Being discontinued Nov 14, 2025 · Updated Nov 14, 2025Discontinuation of the manufacture of the drug
  • Tazicef, Injection, 2 g (NDC 0409-5093-11)Hospira, Inc., a Pfizer Company · Being discontinued Nov 14, 2025 · Updated Nov 14, 2025Discontinuation of the manufacture of the drug

Ceftriaxone Sodium Injection Anti-Infective

  • Ceftriaxone Sodium in Plastic Container, Injection, 1g/50mL (NDC 0338-5002-41)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug
  • Ceftriaxone Sodium in Plastic Container, Injection, 2g/100 mL (NDC 0338-5003-41)Baxter Healthcare · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacture of the drug

Chlorothiazide Oral Suspension Cardiovascular

  • Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)Salix Pharmaceuticals, a division of Bausch Health US, LLC · Being discontinued Feb 10, 2026 · Updated Feb 10, 2026

Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops Anti-Infective

  • Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)Sandoz Inc. · Being discontinued Oct 30, 2026 · Updated Oct 30, 2026Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70

Cisatracurium Besylate Injection Analgesia/Addiction

  • Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02)Hospira, Inc., a Pfizer Company · Being discontinued Sep 11, 2026 · Updated Sep 11, 2026Supply expected to exhaust November 2026; Discontinuation of the manufacture of the drug
  • Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)Hospira, Inc., a Pfizer Company · Being discontinued May 6, 2026 · Updated May 6, 2026Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug
  • Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)Hospira, Inc., a Pfizer Company · Being discontinued May 6, 2026 · Updated May 6, 2026Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug

Clindamycin Hydrochloride Capsule Anti-Infective

  • Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)Pfizer Inc. · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026Discontinuation of the manufacture of the drug
  • Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)Pfizer Inc. · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026Discontinuation of the manufacture of the drug
  • Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)Pfizer Inc. · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026Discontinuation of the manufacture of the drug

Clindamycin Palmitate Hydrochloride Injection Anti-Infective

  • Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)Amneal Pharmaceuticals · Being discontinued Mar 26, 2026 · Updated Mar 26, 2026Discontinuation of the manufacture of the drug

Crinecerfont Capsule Endocrinology/Metabolism

  • Crenessity, Capsule, 25 mg (NDC 70370-5025-1)Neurocrine Biosciences, Inc. · Being discontinued Apr 28, 2026 · Updated Apr 28, 2026Neurocrine is discontinuing only the 25 mg soft gel capsule dose strength (NDC 70370-5025-01). The 50mg and 100mg soft gel capsule dose strength (NDC 70370-5050-1 and 70370-5100-1), and 50 mg/mL oral solution will...

Dacomitinib Tablet Oncology

  • Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)Pfizer Inc. · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)Pfizer Inc. · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)Pfizer Inc. · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug

Dapsone Gel Dermatology

  • Dapsone, Gel, 7.5% (NDC 69238-1627-6)Amneal Pharmaceuticals · Being discontinued Mar 27, 2026 · Updated Mar 27, 2026Discontinuation of the manufacture of the drug

Daptomycin Injection Anti-Infective

  • Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuation of the manufacture of the drug; Marketed by Hikma Pharmaceuticals USA, Inc.
  • Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuation of the manufacture of the drug

Decitabine Injection Oncology

  • Decitabine, Injection, 50 mg (NDC 50742-430-01)Ingenus Pharmaceuticals LLC · Being discontinued Feb 20, 2026 · Updated Feb 20, 2026Discontinuation of the manufacture of the drug
  • Decitabine, Injection, 50 mg (NDC 68001-573-41)Ingenus Pharmaceuticals LLC · Being discontinued Feb 20, 2026 · Updated Feb 20, 2026Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug

Dehydrated Alcohol Injection, Solution Cardiovascular

  • Dehydrated Alcohol, Injection, Solution, 1 mL/1 mL (10 pack) (NDC 16729-710-45)Accord Healthcare Inc. · Being discontinued May 27, 2026 · Updated May 27, 2026Accord is transitioning to the 5-pack configuration (NDC 16729-710-53).

Desflurane Liquid for Inhalation Anesthesia

  • Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86)Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) · Being discontinued Jul 2, 2026 · Updated Jul 2, 2026Discontinuation of the manufacture of the drug; Distributed by Sandoz, Inc.

Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution Renal

  • DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95)Fresenius Medical Care North America · Being discontinued Sep 10, 2026 · Updated Sep 10, 2026A business decision was made to discontinue manufacture of the drug.

Diclofenac Sodium Tablet, Delayed Release Musculoskeletal, Rheumatology

  • Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.
  • Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.
  • Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.
  • Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.
  • Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.
  • Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.

Diltiazem Hydrochloride Injection Cardiovascular

  • Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)Hospira, Inc., a Pfizer Company · Being discontinued Jan 5, 2026 · Updated Jan 5, 2026Discontinuation of the manufacture of the drug

Disopyramide Phosphate Capsule, Extended Release Cardiovascular

  • Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)Pfizer Inc. · Being discontinued Aug 24, 2026 · Updated Aug 24, 2026Discontinuation of the manufacture of the drug
  • Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)Pfizer Inc. · Being discontinued Aug 24, 2026 · Updated Aug 24, 2026Discontinuation of the manufacture of the drug

Docetaxel Injection Oncology

  • Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)Ingenus Pharmaceuticals LLC · Being discontinued Feb 20, 2026 · Updated Feb 20, 2026A business decision was made to discontinue manufacture of the drug.
  • Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)Ingenus Pharmaceuticals LLC · Being discontinued Feb 20, 2026 · Updated Feb 20, 2026A business decision was made to discontinue manufacture of the drug.

Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release Neurology

  • Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)Amneal Pharmaceuticals · Being discontinued Jun 15, 2026 · Updated Jun 15, 2026Discontinuation of the manufacture of the drug
  • Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)Amneal Pharmaceuticals · Being discontinued Jun 15, 2026 · Updated Jun 15, 2026Discontinuation of the manufacture of the drug

Doxercalciferol Injection Endocrinology/Metabolism

  • Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1)Sanofi-Aventis U.S. LLC · Being discontinued Dec 10, 2025 · Updated Dec 10, 2025Discontinuation of the manufacture of the drug
  • Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1)Sanofi-Aventis U.S. LLC · Being discontinued Dec 10, 2025 · Updated Dec 10, 2025Discontinuation of the manufacture of the drug
  • Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1)Sanofi-Aventis U.S. LLC · Being discontinued Dec 10, 2025 · Updated Dec 10, 2025Discontinuation of the manufacture of the drug

Doxycycline Hyclate Tablet Anti-Infective

  • Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026Discontinuation of the manufacture of the drug
  • Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-13)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026Discontinuation of the manufacture of the drug

Doxycycline Hyclate Tablet, Delayed Release Anti-Infective

  • Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)Teva Pharmaceuticals USA, Inc. · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug
  • Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)Teva Pharmaceuticals USA, Inc. · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug

Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release Other

  • Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026A business decision was made to discontinue manufacture of the drug.

Emtricitabine Capsule Anti-Infective

  • Emtriva, Capsule, 200 mg (NDC 61958-0601-1)Gilead Sciences, Inc. · Being discontinued Jun 17, 2026 · Updated Jun 17, 2026Product expected to be available until March 2027

Emtricitabine Oral Solution Anti-Infective

  • Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1)Gilead Sciences, Inc. · Being discontinued Jun 17, 2026 · Updated Jun 17, 2026Product expected to be available until March 2027

Enoxaparin Sodium Injection Hematology

  • Enoxaparin Sodium, Injection, 100 mg/1 mL (NDC 0955-1010-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 120 mg/.8 mL (NDC 0955-1012-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 150 mg/1 mL (NDC 0955-1015-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 30 mg/.3 mL (NDC 0955-1003-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 300 mg/3 mL (NDC 0955-1016-01)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 40 mg/.4 mL (NDC 0955-1004-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 60 mg/.6 mL (NDC 0955-1006-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Enoxaparin Sodium, Injection, 80 mg/.8 mL (NDC 0955-1008-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 100 mg/1 mL (NDC 0075-0623-00)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 100 mg/1 mL (NDC 0075-8020-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 120 mg/.8 mL (NDC 0075-2912-01)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 120 mg/.8 mL (NDC 0075-8022-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 150 mg/1 mL (NDC 0075-2915-01)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 150 mg/1 mL (NDC 0075-8025-10)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...
  • Lovenox, Injection, 30 mg/.3 mL (NDC 0075-0624-30)Sanofi-Aventis U.S. LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available...

And 9 more presentations.

Etravirine Tablet Antiviral

  • Etravirine, Tablet, 100 mg (NDC 10147-0570-1)Janssen Research and Development · Being discontinued Apr 28, 2026 · Updated Apr 28, 2026Discontinuation of the manufacture of the drug
  • Intelence, Tablet, 100 mg (NDC 59676-570-01)Janssen Research and Development · Being discontinued Apr 28, 2026 · Updated Apr 28, 2026Discontinuation of the manufacture of the drug

Everolimus Tablet Transplant

  • Everolimus, Tablet, .25 mg (NDC 49884-158-02)Par Health, USA LLC · Being discontinued Oct 14, 2026 · Updated Oct 14, 2026A business decision was made to withdraw from sale.
  • Everolimus, Tablet, .5 mg (NDC 49884-159-02)Par Health, USA LLC · Being discontinued Oct 14, 2026 · Updated Oct 14, 2026A business decision was made to withdraw from sale.
  • Everolimus, Tablet, .75 mg (NDC 49884-160-02)Par Health, USA LLC · Being discontinued Oct 14, 2026 · Updated Oct 14, 2026A business decision was made to withdraw from sale.
  • Everolimus, Tablet, 1 mg (NDC 49884-283-02)Par Health, USA LLC · Being discontinued Oct 14, 2026 · Updated Oct 14, 2026A business decision was made to withdraw from sale.
  • Everolimus, Tablet, 10 mg (NDC 0093-7769-24)Teva Pharmaceuticals USA, Inc. · Being discontinued Mar 2, 2026 · Updated Mar 2, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 10 mg (NDC 49884-128-91)Endo Pharmaceuticals, Inc. · Being discontinued Jan 6, 2026 · Updated Jan 6, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)Teva Pharmaceuticals USA, Inc. · Being discontinued Mar 2, 2026 · Updated Mar 2, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 2.5 mg (NDC 49884-119-91)Endo Pharmaceuticals, Inc. · Being discontinued Jan 6, 2026 · Updated Jan 6, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 5 mg (NDC 0093-7767-24)Teva Pharmaceuticals USA, Inc. · Being discontinued Mar 2, 2026 · Updated Mar 2, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 5 mg (NDC 49884-125-91)Endo Pharmaceuticals, Inc. · Being discontinued Jan 6, 2026 · Updated Jan 6, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)Teva Pharmaceuticals USA, Inc. · Being discontinued Mar 2, 2026 · Updated Mar 2, 2026Discontinuation of the manufacture of the drug
  • Everolimus, Tablet, 7.5 mg (NDC 49884-127-91)Endo Pharmaceuticals, Inc. · Being discontinued Jan 6, 2026 · Updated Jan 6, 2026Discontinuation of the manufacture of the drug

Felodipine Tablet, Extended Release Cardiovascular

  • Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-21)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product
  • Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product
  • Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-21)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product
  • Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product

Felodipine Tablet, Film Coated, Extended Release Cardiovascular

  • Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-21)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product
  • Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-28)Par Health, USA LLC · Being discontinued Oct 1, 2026 · Updated Oct 7, 2026Discontinuation in the manufacturing of the drug product

Fluocinonide Ointment Dermatology

  • Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-15)Teva Pharmaceuticals USA, Inc. · Being discontinued Oct 2, 2026 · Updated Oct 2, 2026Discontinuation of the manufacture of the drug
  • Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-30)Teva Pharmaceuticals USA, Inc. · Being discontinued Oct 2, 2026 · Updated Oct 2, 2026Discontinuation of the manufacture of the drug
  • Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-92)Teva Pharmaceuticals USA, Inc. · Being discontinued Oct 2, 2026 · Updated Oct 2, 2026Discontinuation of the manufacture of the drug

Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered Pulmonary/Allergy

  • Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.
  • Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.
  • Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22)GlaxoSmithKline · Being discontinued Jul 27, 2026 · Updated Jul 27, 2026The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026. The 120 dose presentation of this product will still be available.

Fluvastatin Sodium Tablet, Extended Release Cardiovascular

  • Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)Sandoz Inc. · Being discontinued Jan 27, 2026 · Updated Jan 27, 2026Discontinuation of the manufacture of the drug
  • Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)Sandoz Inc. · Being discontinued Jan 27, 2026 · Updated Jan 27, 2026Discontinuation of the manufacture of the drug
  • Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31)Sandoz Inc. · Being discontinued Jan 27, 2026 · Updated Jan 27, 2026Discontinuation of the manufacture of the drug

Fosaprepitant Dimeglumine Injection Gastroenterology

  • Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)Fresenius Kabi USA, LLC · Being discontinued Apr 8, 2026 · Updated Apr 8, 2026Discontinuation of the manufacture of the drug

Frovatriptan Succinate Tablet Neurology

  • Frova, Tablet, 2.5 mg (NDC 63481-025-09)Endo Pharmaceuticals, Inc. · Being discontinued Feb 24, 2026 · Updated Feb 24, 2026A business decision was made to discontinue manufacture of the drug.

Fulvestrant Injection Oncology

  • Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)Fresenius Kabi USA, LLC · Being discontinued Aug 14, 2026 · Updated Aug 14, 2026Discontinuation of the manufacture of the drug

Gadobutrol Injection Medical Imaging

  • Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA
  • Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA
  • Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA
  • Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 30, 2026 · Updated Jun 30, 2026Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA

Gadoterate Meglumine Injection Medical Imaging

  • Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued May 21, 2026 · Updated May 21, 2026Discontinuation of the manufacture of the drug
  • Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued May 21, 2026 · Updated May 21, 2026Discontinuation of the manufacture of the drug
  • Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued May 21, 2026 · Updated May 21, 2026Discontinuation of the manufacture of the drug
  • Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued May 21, 2026 · Updated May 21, 2026Discontinuation of the manufacture of the drug

Gemfibrozil Tablet Endocrinology/Metabolism

  • Lopid, Tablet, 600 mg (NDC 0071-0737-20)Pfizer Inc. · Being discontinued Feb 10, 2026 · Updated Feb 10, 2026Discontinuation of the manufacture of the drug.

Glyburide Tablet Endocrinology/Metabolism

  • Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53)Sanofi-Aventis U.S. LLC · Being discontinued Aug 10, 2026 · Updated Aug 10, 2026A business decision was made to discontinue manufacture of the drug.
  • Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01)Sanofi-Aventis U.S. LLC · Being discontinued Aug 10, 2026 · Updated Aug 10, 2026A business decision was made to discontinue manufacture of the drug.
  • Diabeta, Tablet, 5 mg (NDC 0093-9364-01)Sanofi-Aventis U.S. LLC · Being discontinued Aug 10, 2026 · Updated Aug 10, 2026A business decision was made to discontinue manufacture of the drug.
  • Diabeta, Tablet, 5 mg (NDC 0093-9364-10)Sanofi-Aventis U.S. LLC · Being discontinued Aug 10, 2026 · Updated Aug 10, 2026A business decision was made to discontinue manufacture of the drug.

Glycerol Phenylbutyrate Oral Liquid Inborn Errors

  • RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06)Amgen Inc. · Being discontinued Sep 1, 2026 · Updated Sep 1, 2026Discontinuation in the manufacturing of the drug product
  • RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07)Amgen Inc. · Being discontinued Sep 1, 2026 · Updated Sep 1, 2026Discontinuation in the manufacturing of the drug product

Glycopyrrolate Injection Anesthesia

  • Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)Fresenius Kabi USA, LLC · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug
  • Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)Fresenius Kabi USA, LLC · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug
  • Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)Fresenius Kabi USA, LLC · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug
  • Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)Fresenius Kabi USA, LLC · Being discontinued Jul 30, 2026 · Updated Jul 30, 2026Discontinuation of the manufacture of the drug

Haloperidol Decanoate Injection Psychiatry

  • Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)Fresenius Kabi USA, LLC · Being discontinued Jan 9, 2026 · Updated Jan 9, 2026Discontinuation of the manufacture of the drug
  • Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)Fresenius Kabi USA, LLC · Being discontinued Jan 9, 2026 · Updated Jan 9, 2026Discontinuation of the manufacture of the drug

Hydrochlorothiazide Capsule Cardiovascular

  • Microzide, Capsule, 12.5 mg (NDC 0591-0347-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.
  • Microzide, Capsule, 12.5 mg (NDC 0591-0347-05)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.

Hydrocortisone Acetate Suppository Analgesia/Addiction, Other

  • Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Hydromorphone Hydrochloride Suppository Analgesia/Addiction

  • Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Hydroxychloroquine Sulfate Tablet Anti-Infective, Other, Rheumatology

  • Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Jan 5, 2026 · Updated Jan 5, 2026Discontinuation of the manufacture of the drug

Icatibant Acetate Injection Hematology

  • Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86)Fresenius Kabi USA, LLC · Being discontinued May 7, 2026 · Updated May 7, 2026Discontinuation of the manufacturer of the drug
  • Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)Fresenius Kabi USA, LLC · Being discontinued May 7, 2026 · Updated May 7, 2026Discontinuation of the manufacturer of the drug

Icosapent Ethyl Capsule Cardiovascular

  • Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12)Apotex Corp. · Being discontinued Apr 1, 2026 · Updated Apr 1, 2026Discontinuation of the manufacture of the drug
  • Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)Apotex Corp. · Being discontinued Apr 1, 2026 · Updated Apr 1, 2026Discontinuation of the manufacture of the drug

Idelalisib Tablet Oncology

  • Zydelig, Tablet, 100 mg (NDC 61958-1701-1)Gilead Sciences, Inc. · Being discontinued Apr 7, 2026 · Updated Apr 7, 2026Discontinuation in the manufacturing of the drug
  • Zydelig, Tablet, 150 mg (NDC 61958-1702-1)Gilead Sciences, Inc. · Being discontinued Apr 7, 2026 · Updated Apr 7, 2026Discontinuation in the manufacturing of the drug

Imipenem and Cilastatin Injection Anti-Infective

  • Primaxin, Injection, 500mg (NDC 0006-3516-59)Merck Sharp & Dohme Corp. · Being discontinued Jan 8, 2026 · Updated Jan 8, 2026To be discontinued approximately 11/30/2026

Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection Anti-Infective

  • RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)Merck Sharp & Dohme LLC · Being discontinued Sep 9, 2026 · Updated Sep 9, 2026To be discontinued on or near late September 2026.

Insulin Glargine-aglr Injection Endocrinology/Metabolism

  • Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)Eli Lilly and Co. · Being discontinued Sep 1, 2026 · Updated Sep 1, 2026A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday...

Insulin Lispro Injection Endocrinology/Metabolism

  • Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)Eli Lilly and Co. · Being discontinued Sep 1, 2026 · Updated Sep 1, 2026A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday...

Insulin Lispro Protamine and Insulin Lispro Injection Endocrinology/Metabolism

  • Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05)Eli Lilly and Co. · Being discontinued Sep 1, 2026 · Updated Sep 1, 2026A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday...

Irinotecan Hydrochloride Injection Oncology

  • Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)Ingenus Pharmaceuticals LLC · Being discontinued Feb 24, 2026 · Updated Feb 24, 2026A business decision was made to discontinue manufacture of the drug.
  • Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)Ingenus Pharmaceuticals LLC · Being discontinued Feb 24, 2026 · Updated Feb 24, 2026A business decision was made to discontinue manufacture of the drug.

Iron Sucrose Injection Hematology

  • Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)Mylan Institutional, a Viatris Company · Being discontinued May 21, 2026 · Updated May 21, 2026A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10...

Itraconazole Capsule Anti-Infective, Other

  • Sporanox, Capsule, 100 mg (NDC 10147-1700-3)Janssen Pharmaceuticals · Being discontinued Feb 27, 2026 · Updated Feb 27, 2026Discontinuation of the manufacture of the drug
  • Sporanox, Capsule, 100 mg (NDC 50458-290-01)Janssen Pharmaceuticals · Being discontinued Feb 27, 2026 · Updated Feb 27, 2026Discontinuation of the manufacture of the drug
  • Sporanox, Capsule, 100 mg (NDC 50458-290-04)Janssen Pharmaceuticals · Being discontinued Feb 27, 2026 · Updated Feb 27, 2026Discontinuation of the manufacture of the drug

Ivabradine Hydrochloride Tablet Cardiovascular

  • Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)Amgen Inc. · Being discontinued Jan 1, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug product
  • Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)Amgen Inc. · Being discontinued Jan 1, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug product

Ivabradine Solution Cardiovascular

  • Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28)Amgen Inc. · Being discontinued Jan 1, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug product

Ivermectin Tablet Anti-Infective

  • STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01)Merck Sharp & Dohme LLC · Being discontinued Sep 29, 2026 · Updated Sep 29, 2026Product will be discontinued on 10/31/2026

Ketorolac Tromethamine Tablet Analgesia/Addiction

  • Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Apr 20, 2026 · Updated Apr 20, 2026Discontinuation of the manufacture of the drug

Lamivudine Tablet Antiviral

  • Epivir, Tablet, 150 mg (NDC 49702-203-18)ViiV Healthcare Company · Being discontinued Oct 19, 2026 · Updated Oct 19, 2026The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
  • Epivir, Tablet, 300 mg (NDC 49702-204-13)ViiV Healthcare Company · Being discontinued Oct 19, 2026 · Updated Oct 19, 2026The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug

Lamotrigine Tablet, Extended Release Neurology

  • Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug
  • Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)Par Health, Inc. · Being discontinued Apr 29, 2026 · Updated Apr 29, 2026Discontinuation of the manufacture of the drug

Leflunomide Tablet Rheumatology

  • Arava, Tablet, 10 mg (NDC 0088-2160-30)Sanofi-Aventis U.S. LLC · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Arava, Tablet, 100 mg (NDC 0088-2162-33)Sanofi-Aventis U.S. LLC · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Arava, Tablet, 20 mg (NDC 0088-2161-30)Sanofi-Aventis U.S. LLC · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Leflunomide, Tablet, 10 mg (NDC 0955-1735-30)Sanofi-Aventis U.S. LLC · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug
  • Leflunomide, Tablet, 20 mg (NDC 0955-1737-30)Sanofi-Aventis U.S. LLC · Being discontinued Jun 8, 2026 · Updated Jun 8, 2026Discontinuation of the manufacture of the drug

Leuprolide Acetate Injection Oncology

  • Leuprolide Acetate, Injection, 14 mg/2.8 mL (1 mg/0.2 mL) (NDC 70121-2537-6)Amneal Pharmaceuticals · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026A business decision was made to discontinue manufacture of the drug.

Lincomycin Hydrochloride Injection Anti-Infective

  • Lincocin, Injection, 10 mL multiple dose vial (NDC 0009-0107-04)Pfizer Inc. · Being discontinued Nov 6, 2026 · Updated Nov 6, 2026Discontinuation of the manufacture of the drug
  • Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)Pfizer Inc. · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026Discontinuation of the manufacture of the drug
  • Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)XGen Pharmaceuticals DJB, Inc. · Being discontinued Mar 26, 2026 · Updated Mar 26, 2026A business decision was made to discontinue manufacture of the drug.
  • Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2)XGen Pharmaceuticals DJB, Inc. · Being discontinued Mar 26, 2026 · Updated Mar 26, 2026A business decision was made to discontinue manufacture of the drug.

Lopinavir and Ritonavir Oral Solution Antiviral

  • Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug

Lopinavir and Ritonavir Tablet Antiviral

  • Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug
  • Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug
  • Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug
  • Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug

Lorlatinib Tablet Oncology

  • Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)Pfizer Inc. · Being discontinued Jun 15, 2026 · Updated Jun 15, 2026Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentation

Maraviroc Solution Antiviral

  • Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton (NDC 49702-260-55)ViiV Healthcare Company · Being discontinued Jan 20, 2026 · Updated Jan 20, 2026The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.

Medroxyprogesterone Acetate Tablet Urology

  • PROVERA, Tablet, 10 mg (NDC 0009-0051-01)Pfizer Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.
  • PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)Pfizer Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.

Melphalan Hydrochloride Injection Oncology

  • Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20)Fresenius Kabi USA, LLC · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Discontinuation of the manufacture of the drug

Mesalamine Capsule, Extended Release Gastroenterology

  • Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Aug 25, 2026 · Updated Aug 25, 2026Discontinuation of the manufacture of the drug
  • Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)Takeda Pharmaceuticals USA Inc. · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Product is anticipated to be available until December 31, 2027
  • Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)Takeda Pharmaceuticals USA Inc. · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Product is anticipated to be available until December 31, 2027

Metformin Hydrochloride Tablet, Extended Release Endocrinology/Metabolism

  • Metformin Hydrochloride, Tablet, Extended Release, 1000 mg (NDC 0378-6001-91)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Oct 22, 2026 · Updated Oct 22, 2026A business decision was made was discontinue manufacture of the drug product.
  • Metformin Hydrochloride, Tablet, Extended Release, 500 mg (NDC 0378-6002-91)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Oct 22, 2026 · Updated Oct 22, 2026A business decision was made was discontinue manufacture of the drug product.

Metoprolol Succinate Tablet, Extended Release Cardiovascular

  • Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.
  • Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)Teva Pharmaceuticals USA, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026A business decision was made to discontinue manufacture of the drug.

Micafungin Sodium Injection Anti-Infective

  • Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10)Par Health, USA LLC · Being discontinued Sep 11, 2026 · Updated Sep 11, 2026A business decision was made to discontinue manufacture of the drug.
  • Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10)Par Health, USA LLC · Being discontinued Sep 11, 2026 · Updated Sep 11, 2026A business decision was made to discontinue manufacture of the drug.

Mirikizumab-mrkz Injection Gastroenterology, Other

  • Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)Eli Lilly and Co. · Being discontinued Dec 22, 2025 · Updated Dec 22, 2025A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.
  • Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)Eli Lilly and Co. · Being discontinued Dec 22, 2025 · Updated Dec 22, 2025A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain.

Molnupiravir Capsule Anti-Infective

  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)Merck Sharp & Dohme LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug
  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)Merck Sharp & Dohme LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug
  • Lagevrio, Capsule, 200 mg (NDC 0006-5055-09)Merck Sharp & Dohme LLC · Being discontinued Oct 20, 2026 · Updated Oct 20, 2026Discontinuation of the manufacture of the drug

Montelukast Sodium Tablet, Chewable Pulmonary/Allergy

  • Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)Organon · Being discontinued Nov 17, 2025 · Updated Nov 17, 2025Discontinuation of the manufacture of the drug

Morphine Sulfate Suppository Analgesia/Addiction

  • Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug
  • Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Morphine Sulfate Tablet Analgesia/Addiction

  • Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11)Upsher-Smith Laboratories, LLC · Being discontinued Dec 22, 2025 · Updated Dec 22, 2025Discontinuation of the manufacture of the drug
  • Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11)Upsher-Smith Laboratories, LLC · Being discontinued Dec 22, 2025 · Updated Dec 22, 2025Discontinuation of the manufacture of the drug

Nebivolol Hydrochloride Tablet Cardiovascular

  • Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug
  • Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30)Torrent Pharmaceuticals Limited · Being discontinued Mar 25, 2026 · Updated Mar 25, 2026Discontinuation of the manufacture of the drug

And 1 more presentations.

Neostigmine Methylsulfate Injection Analgesia/Addiction

  • Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)Fresenius Kabi USA, LLC · Being discontinued Jan 12, 2026 · Updated Jan 12, 2026Discontinuation of the manufacture of the drug

Nilutamide Tablet Oncology

  • Nilandron, Tablet, 150 mg (NDC 59212-111-14)Advanz Pharma (US) Corp. · Being discontinued Dec 1, 2025 · Updated Dec 1, 2025Product to expire in March 2026; Discontinuation of the manufacture of the drug
  • Nilandron, Tablet, 150 mg (NDC 66993-212-38)Advanz Pharma (US) Corp. · Being discontinued Dec 1, 2025 · Updated Dec 1, 2025Product to expire in March 2026; Discontinuation of the manufacture of the drug

Nitrofurantoin Oral Suspension Anti-Infective, Other

  • Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9)Amneal Pharmaceuticals · Being discontinued Apr 10, 2026 · Updated Apr 10, 2026Discontinuation of the manufacture of the drug

Nitroglycerin Ointment Analgesia/Addiction

  • Rectiv, Ointment, 0.4% (NDC 58914-301-80)AbbVie Inc. · Being discontinued Apr 14, 2026 · Updated Apr 14, 2026Discontinuation of the manufacture of the drug

Oxaliplatin Injection Oncology

  • Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 29, 2026 · Updated Jun 29, 2026Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
  • Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)Jiangsu Hengrui Pharmaceuticals Co., Ltd. · Being discontinued Jun 29, 2026 · Updated Jun 29, 2026Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug
  • Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)Fresenius Kabi USA, LLC · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026A business decision was made to discontinue manufacture of the drug.
  • Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)Fresenius Kabi USA, LLC · Being discontinued Feb 25, 2026 · Updated Feb 25, 2026A business decision was made to discontinue manufacture of the drug.

Palbociclib Capsule Oncology

  • Ibrance, Capsule, 100 mg (NDC 0069-0188-21)Pfizer Inc. · Being discontinued Apr 22, 2026 · Updated Apr 22, 2026Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured.
  • Ibrance, Capsule, 75 mg (NDC 0069-0187-21)Pfizer Inc. · Being discontinued Apr 22, 2026 · Updated Apr 22, 2026Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet NDC 0069-0284-03 will continue to be manufactured.

Palonosetron Hydrochloride Injection Gastroenterology

  • Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 14, 2025 · Updated Nov 14, 2025Discontinuation of the manufacture of the drug

Palovarotene Capsule Musculoskeletal

  • SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)Ipsen Biopharmaceuticals, Inc. · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug

Pentamidine Isethionate Injection Anti-Infective

  • Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)XGen Pharmaceuticals DJB, Inc. · Being discontinued Mar 23, 2026 · Updated Mar 23, 2026A business decision was made to discontinue manufacture of the drug.

Peritoneal Dialysis Solution Renal

  • DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
  • DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
  • DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
  • DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
  • DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.
  • DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)Fresenius Medical Care North America · Being discontinued Mar 10, 2026 · Updated Mar 10, 2026The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.

Phenoxybenzamine Hydrochloride Capsule Cardiovascular

  • Dibenzyline, Capsule, 10 mg (NDC 59212-001-01)Advanz Pharma (US) Corp. · Being discontinued Dec 1, 2025 · Updated Dec 1, 2025Discontinuation of the manufacture of the drug
  • Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)Advanz Pharma (US) Corp. · Being discontinued Dec 1, 2025 · Updated Dec 1, 2025Discontinuation of the manufacture of the drug
  • Dibenzyline, Capsule, 10 mg (NDC 66993-066-02)Advanz Pharma (US) Corp. · Being discontinued Dec 1, 2025 · Updated Dec 1, 2025Discontinuation of the manufacture of the drug

Pilocarpine Hydrochloride Ophthalmic Solution Ophthalmology

  • Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)AbbVie Inc. · Being discontinued Mar 24, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug
  • Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03)AbbVie Inc. · Being discontinued Mar 24, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug
  • Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)AbbVie Inc. · Being discontinued Mar 24, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug
  • Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05)AbbVie Inc. · Being discontinued Mar 24, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug
  • Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06)AbbVie Inc. · Being discontinued Mar 24, 2026 · Updated Mar 24, 2026Discontinuation of the manufacture of the drug

Pindolol Tablet Cardiovascular

  • Pindolol, Tablet, 10 mg (NDC 57664-656-88)Sun Pharmaceutical Industries, Inc. · Being discontinued Jan 30, 2026 · Updated Jan 30, 2026Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026
  • Pindolol, Tablet, 5 mg (NDC 57664-655-88)Sun Pharmaceutical Industries, Inc. · Being discontinued Jan 30, 2026 · Updated Jan 30, 2026Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027

Piperacillin and Tazobactam Injection Anti-Infective

  • Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)Fresenius Kabi USA, LLC · Being discontinued Jan 20, 2026 · Updated Jan 20, 2026Discontinuation of the manufacture of the drug

Plerixafor Injection Hematology

  • Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)Fresenius Kabi USA, LLC · Being discontinued Mar 13, 2026 · Updated Mar 13, 2026A business decision was made to discontinue manufacture of the drug.

Podofilox Topical Gel Dermatology, Other

  • Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)AbbVie Inc. · Being discontinued Jan 28, 2026 · Updated Jan 28, 2026Discontinuation of the manufacture of the drug

Podophyllum Resin Topical Tincture Dermatology

  • Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)Padagis US LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid, Sodium Chloride, and Potassium Chloride Oral Solution Gastroenterology

  • Plenvu, Oral Solution, KIT (NDC 65649-400-01)Salix Pharmaceuticals, a division of Bausch Health US, LLC · Being discontinued Aug 13, 2026 · Updated Aug 13, 2026A business decision was made to discontinue manufacture of the drug.

Posaconazole Injection Anti-Infective

  • Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)Merck Sharp & Dohme Corp. · Being discontinued Dec 2, 2025 · Updated Dec 2, 2025Discontinuation of the manufacture of the drug

Potassium Chloride Tablet, Extended Release Endocrinology/Metabolism, Gastroenterology

  • Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 21, 2025 · Updated Nov 21, 2025Discontinuation of the manufacture of the drug
  • Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 21, 2025 · Updated Nov 21, 2025Discontinuation of the manufacture of the drug
  • Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 21, 2025 · Updated Nov 21, 2025Discontinuation of the manufacture of the drug
  • Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10)Teva Pharmaceuticals USA, Inc. · Being discontinued Nov 21, 2025 · Updated Nov 21, 2025Discontinuation of the manufacture of the drug

Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution Cardiovascular

  • Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10)Fresenius Kabi USA, LLC · Being discontinued Aug 31, 2026 · Updated Aug 31, 2026Discontinuation of the manufacture of the drug

Prazosin Hydrochloride Capsule Cardiovascular

  • Minipress, Capsule, 1 mg (NDC 0069-4310-71)Pfizer Inc. · Being discontinued Apr 28, 2023 · Updated Apr 28, 2023Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023
  • Minipress, Capsule, 2 mg (NDC 0069-4370-71)Pfizer Inc. · Being discontinued Apr 28, 2023 · Updated Apr 28, 2023Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023
  • Minipress, Capsule, 5 mg (NDC 0069-4380-71)Pfizer Inc. · Being discontinued Apr 28, 2023 · Updated Apr 28, 2023Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023

Progesterone Vaginal Gel Urology

  • Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)AbbVie Inc. · Being discontinued Mar 27, 2026 · Updated Mar 27, 2026Discontinuation of the manufacture of the drug

Ramelteon Tablet Psychiatry

  • Rozerem, Tablet, 8 mg (NDC 64764-805-10)Takeda Pharmaceuticals USA Inc. · Being discontinued Mar 19, 2026 · Updated Mar 19, 2026Product is expected to be available through February 2027.
  • Rozerem, Tablet, 8 mg (NDC 64764-805-30)Takeda Pharmaceuticals USA Inc. · Being discontinued Mar 19, 2026 · Updated Mar 19, 2026Product is expected to be available through June 2027.

Riboflavin 5-phosphate Ophthalmic Solution Ophthalmology

  • Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)Glaukos Corporation · Being discontinued Jan 20, 2026 · Updated Jan 20, 2026Discontinuing manufacture of the product as of July 2026.

Ritonavir Oral Powder Antiviral

  • Norvir, Oral Powder, 100 mg (NDC 0074-3399-30)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug

Ritonavir Tablet Antiviral

  • Norvir, Tablet, 100 mg (NDC 0074-2340-30)AbbVie Inc. · Being discontinued Jul 24, 2026 · Updated Jul 24, 2026Discontinuation of the manufacture of the drug

Rivaroxaban For Suspension Hematology

  • Xarelto, For Suspension, 155 mg (NDC 50458-575-01)Janssen Pharmaceuticals · Being discontinued Sep 18, 2026 · Updated Sep 18, 2026Business Decision

Rivastigmine Film, Extended Release Neurology

  • Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Sep 18, 2026 · Updated Sep 18, 2026Discontinuation of the manufacture of the drug.

Semaglutide Tablet Endocrinology/Metabolism

  • Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
  • Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.
  • Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)Novo Nordisk, Inc. · Being discontinued Jun 4, 2026 · Updated Jun 4, 2026Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.

Sodium Chloride 0.9% Injection Gastroenterology, Other, Renal

  • Sodium Chloride 0.9%, Injection, 100 mL ADD-Vantage® Flexible Container (NDC 0409-7101-67)Hospira, Inc., a Pfizer Company · Being discontinued Dec 3, 2025 · Updated Dec 3, 2025Discontinuation of the manufacture of the drug
  • Sodium Chloride 0.9%, Injection, 250 mL ADD-Vantage® Flexible Container (NDC 0409-7101-02)Hospira, Inc., a Pfizer Company · Being discontinued Dec 3, 2025 · Updated Dec 3, 2025Discontinuation of the manufacture of the drug
  • Sodium Chloride 0.9%, Injection, 50 mL ADD-Vantage® Flexible Container (NDC 0409-7101-66)Hospira, Inc., a Pfizer Company · Being discontinued Dec 3, 2025 · Updated Dec 3, 2025Discontinuation of the manufacture of the drug

Sodium Oxybate Solution Psychiatry

  • Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1)Amneal Pharmaceuticals · Being discontinued Dec 29, 2025 · Updated Dec 29, 2025Discontinuation of the manufacture of the drug

Somatropin Injection Endocrinology/Metabolism

  • Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)Novo Nordisk, Inc. · Being discontinued Nov 14, 2025 · Updated Nov 14, 2025Discontinuation of the manufacture of the drug

Spironolactone Tablet Cardiovascular

  • Aldactone, Tablet, 100 mg (NDC 0025-1031-31)Pfizer Inc. · Being discontinued Dec 10, 2025 · Updated Dec 10, 2025Discontinuation of the manufacture of the drug.
  • Aldactone, Tablet, 25 mg (NDC 0025-1001-31)Pfizer Inc. · Being discontinued Dec 10, 2025 · Updated Dec 10, 2025Discontinuation of the manufacture of the drug.

Succinylcholine Chloride Injection Anesthesia

  • Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)Fresenius Kabi USA, LLC · Being discontinued Jul 23, 2026 · Updated Jul 23, 2026Discontinuation of the manufacture of the drug

Sulconazole Nitrate Solution Dermatology

  • Exelderm, Solution, 1.0% 30 mL (NDC 69489-721-30)Journey Medical Corporation · Being discontinued May 8, 2026 · Updated May 8, 2026Discontinuation of the manufacture of the drug
  • Exelderm, Solution, 1.0% 5 mL (NDC 69489-721-05)Journey Medical Corporation · Being discontinued May 8, 2026 · Updated May 8, 2026Discontinuation of the manufacture of the drug
  • Sulconazole Nitrate, Solution, 30 mL (NDC 72143-321-30)Journey Medical Corporation · Being discontinued May 8, 2026 · Updated May 8, 2026Discontinuation of the manufacture of the drug. Manufactured for JG Pharma

Tadalafil Tablet Cardiovascular

  • Adcirca, Tablet, 20 mg (NDC 66302-467-60)Eli Lilly and Co. · Being discontinued Nov 5, 2026 · Updated Nov 5, 2026Discontinuation of the manufacture of the drug

Tazemetostat Hydrobromide Tablet Oncology

  • Tazverik, Tablet, 200 mg (NDC 72607-100-00)Epizyme, Inc. (An Ipsen Company) · Being discontinued Mar 27, 2026 · Updated Mar 27, 2026Discontinuation of the manufacture of the drug product

Tiagabine Hydrochloride Tablet Neurology

  • Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)Teva Pharmaceuticals USA, Inc. · Being discontinued Apr 15, 2026 · Updated Apr 15, 2026Discontinuation of the manufacture of the drug
  • Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)Teva Pharmaceuticals USA, Inc. · Being discontinued Apr 15, 2026 · Updated Apr 15, 2026Discontinuation of the manufacture of the drug
  • Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)Teva Pharmaceuticals USA, Inc. · Being discontinued Apr 15, 2026 · Updated Apr 15, 2026Discontinuation of the manufacture of the drug
  • Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)Teva Pharmaceuticals USA, Inc. · Being discontinued Apr 15, 2026 · Updated Apr 15, 2026Discontinuation of the manufacture of the drug

Tobramycin Sulfate Injection Anti-Infective

  • Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01)Hospira, Inc., a Pfizer Company · Being discontinued Jul 17, 2026 · Updated Jul 17, 2026Discontinuation of the manufacture of the drug

Travoprost Ophthalmic Solution Ophthalmology

  • Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Jul 7, 2026 · Updated Jul 7, 2026Discontinuation of the manufacture of the drug
  • Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Jul 7, 2026 · Updated Jul 7, 2026Discontinuation of the manufacture of the drug

Ursodiol Capsule Other

  • Ursodiol, Capsule, 300 mg (NDC 64380-844-06)Strides Pharma Inc. · Being discontinued Apr 6, 2026 · Updated Apr 6, 2026Discontinuation of the manufacture of the drug

Valrubicin Solution Oncology

  • Valstar Preservative Free, Solution, 40 mg/1 mL (NDC 67979-001-01)Endo Operations LTD · Being discontinued Nov 13, 2026 · Updated Nov 13, 2026Discontinuation of the manufacture of the drug

Valsartan Tablet Cardiovascular

  • Valsartan, Tablet, 160 mg (NDC 0378-5814-77)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.
  • Valsartan, Tablet, 320 mg (NDC 0378-5815-77)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.
  • Valsartan, Tablet, 40 mg (NDC 0378-5807-93)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.
  • Valsartan, Tablet, 80 mg (NDC 0378-5813-77)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Nov 19, 2025 · Updated Nov 19, 2025A business decision was made to discontinue manufacture of the drug.

Vancomycin Hydrochloride Injection Anti-Infective

  • Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)Hospira, Inc., a Pfizer Company · Being discontinued Nov 14, 2025 · Updated Nov 14, 2025Discontinuation of the manufacture of the drug

Verapamil Hydrochloride Injection Cardiovascular

  • Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05)Pfizer Inc. · Being discontinued Nov 21, 2025 · Updated Nov 21, 2025Discontinuation of the manufacture of the drug

Vigabatrin Tablet Neurology

  • Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)Hikma Pharmaceuticals USA, Inc. · Being discontinued Oct 16, 2026 · Updated Oct 16, 2026The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness.

Recently resolved

Can't get your medicine?

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.